Neuronetics Inc. (STIM) Prices 4.84M Share Common Offering at $15.50/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Neuronetics Announces Pricing of $75 Million Public Offering of Common Stock
January 28, 2021 10:30 PM ESTMALVERN, Pa., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the Company), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that it has priced the previously announced underwritten public offering of 4,840,000 shares of its common stock, at a public offering price of $15.50 per share. The Company has granted the underwriters a 30-day option to purchase up to an additional 726,000 shares of its common stock. The gross proceeds to the Company from this offering are... More



